Consolidated Statements of Changes in Contingently Redeemable Convertible Preferred Stock and Stockholders’ Equity - USD ($) shares in Thousands, $ in Thousands	Total	Previously Reported	Retroactive application of the recapitalization	Preferred stock	Preferred stock Previously Reported	Preferred stock Retroactive application of the recapitalization	Common Stock	Common Stock Previously Reported	Common Stock Retroactive application of the recapitalization	Additional Paid-in Capital	Additional Paid-in Capital Previously Reported	Additional Paid-in Capital Retroactive application of the recapitalization	Accumulated Deficit	Accumulated Deficit Previously Reported	Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2020				10,826	6,766	4,060
Beginning balance at Dec. 31, 2020				$ 44,476	$ 44,476
Ending balances (in shares) at Sep. 30, 2021				10,826
Ending balance at Sep. 30, 2021				$ 44,476
Beginning balance (in shares) at Dec. 31, 2020							157,786	98,607	59,179
Beginning balance at Dec. 31, 2020	$ 89,224	$ 89,224	$ 0				$ 16	$ 1	$ 15	$ 163,952	$ 163,967	$ (15)	$ (74,744)	$ (74,744)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(13,194)												(13,194)
Other comprehensive income	(8,552)														$ (8,552)
Stock-based compensation (in shares)							0
Stock-based compensation	31,012									31,012
Issuances of common stock- business combination (in shares)							115,508
Issuances of common stock - business combination	1,189,907						$ 1			1,189,906
Issuances of common stock warrants and options (in shares)							40
Issuances of common stock - warrants and options	496									496
Ending balance (in shares) at Sep. 30, 2021							273,334
Ending balance at Sep. 30, 2021	$ 1,288,893						$ 17			1,385,366			(87,938)		(8,552)
Beginning balance (in shares) at Dec. 31, 2020				10,826	6,766	4,060
Beginning balance at Dec. 31, 2020				$ 44,476	$ 44,476
Ending balances (in shares) at Dec. 31, 2021	10,826			10,826
Ending balance at Dec. 31, 2021	$ 44,476			$ 44,476
Beginning balance (in shares) at Dec. 31, 2020							157,786	98,607	59,179
Beginning balance at Dec. 31, 2020	89,224	$ 89,224	$ 0				$ 16	$ 1	$ 15	163,952	$ 163,967	$ (15)	(74,744)	$ (74,744)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Costs attributable to issuance of common stock and equity instruments - Merger with XPDI	$ 16,600
Ending balance (in shares) at Dec. 31, 2021	271,576						271,576
Ending balance at Dec. 31, 2021	$ 1,341,210						$ 27			1,379,581			(27,432)		(10,966)
Beginning balance (in shares) at Jun. 30, 2021				10,826
Beginning balance at Jun. 30, 2021				$ 44,476
Ending balances (in shares) at Sep. 30, 2021				10,826
Ending balance at Sep. 30, 2021				$ 44,476
Beginning balance (in shares) at Jun. 30, 2021							157,826
Beginning balance at Jun. 30, 2021	95,879						$ 16			167,172			(71,309)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(16,629)												(16,629)
Other comprehensive income	(8,552)														(8,552)
Stock-based compensation (in shares)							(40)
Stock-based compensation	28,288									28,288
Issuances of common stock- business combination (in shares)							115,508
Issuances of common stock - business combination	1,189,907						$ 1			1,189,906
Ending balance (in shares) at Sep. 30, 2021							273,334
Ending balance at Sep. 30, 2021	$ 1,288,893						$ 17			1,385,366			(87,938)		(8,552)
Beginning balance (in shares) at Dec. 31, 2021	10,826			10,826
Beginning balance at Dec. 31, 2021	$ 44,476			$ 44,476
Increase (Decrease) in Temporary Equity [Roll Forward]
Conversion of contingently redeemable preferred stock to common stock (in shares)				(10,826)
Conversion of contingently redeemable preferred stock to common stock				$ (44,476)
Ending balances (in shares) at Sep. 30, 2022	0			0
Ending balance at Sep. 30, 2022	$ 0			$ 0
Beginning balance (in shares) at Dec. 31, 2021	271,576						271,576
Beginning balance at Dec. 31, 2021	$ 1,341,210						$ 27			1,379,581			(27,432)		(10,966)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(1,711,471)												(1,711,471)
Other comprehensive income	83,578														83,578
Stock-based compensation	165,949									165,949
Issuance of common stock- employee stock options (in shares)							1,321
Issuance of common stock - employee stock options	3,846									3,846
Issuance of common stock - restricted stock and restricted stock units (in shares)							39,099
Issuance of common stock - restricted stock and restricted stock units, net of shares withheld for tax withholding obligations	$ (31,626)						$ 4			(31,630)
Restricted stock awards cancelled upon forfeiture (in shares)	(2,268)
Issuances of common stock - equity line of credit (in shares)							7,315
Issuances of common stock - equity line of credit	$ 13,040						$ 1			13,039
Issuances of common stock - financing transaction fees (in shares)							1,285
Issuances of common stock - financing transaction fees	2,960						$ 0			2,960
Issuance of common stock - exercise of convertible notes (in shares)							197
Issuance of common stock - exercise of convertible notes	1,574									1,574
Issuance of common stock - exercise of warrants (in shares)							3,001
Issuance of common stock - exercise of warrants	0						$ 0
Conversion of contingently redeemable preferred stock to common stock (in shares)							10,826
Conversion of contingently redeemable preferred stock to common stock	44,476						$ 1			44,475
Issuances of common stock- Merger with XPDI (in shares)							30,778
Issuances of common stock - Merger with XPDI	163,459						$ 3			163,456
Issuances of common stock- vendor settlement (in shares)							1,580
Issuances of common stock - vendor settlement	12,674									12,674
Costs attributable to issuance of common stock and equity instruments - Merger with XPDI	$ (16,642)									(16,642)
Ending balance (in shares) at Sep. 30, 2022	364,710						364,710
Ending balance at Sep. 30, 2022	$ 73,027						$ 36			1,739,282			(1,738,903)		72,612
Beginning balance (in shares) at Jun. 30, 2022				0
Beginning balance at Jun. 30, 2022				$ 0
Ending balances (in shares) at Sep. 30, 2022	0			0
Ending balance at Sep. 30, 2022	$ 0			$ 0
Beginning balance (in shares) at Jun. 30, 2022							353,481
Beginning balance at Jun. 30, 2022	416,452						$ 35			1,695,748			(1,304,111)		24,780
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(434,792)												(434,792)
Other comprehensive income	47,832														47,832
Stock-based compensation	29,884									29,884
Issuance of common stock - restricted stock and restricted stock units (in shares)							4,897
Issuance of common stock - restricted stock and restricted stock units, net of shares withheld for tax withholding obligations	$ (2,349)						$ 0			(2,349)
Restricted stock awards cancelled upon forfeiture (in shares)	(2,268)
Issuances of common stock - equity line of credit (in shares)							7,315
Issuances of common stock - equity line of credit	$ 13,040						$ 1			13,039
Issuances of common stock - financing transaction fees (in shares)							1,285
Issuances of common stock - financing transaction fees	$ 2,960						$ 0			2,960
Ending balance (in shares) at Sep. 30, 2022	364,710						364,710
Ending balance at Sep. 30, 2022	$ 73,027						$ 36			$ 1,739,282			$ (1,738,903)		$ 72,612